The governments of Argentina and Mexico have agreed to produce the AstraZeneca COVID-19 vaccine for most of Latin America. Mexico is in talks with several companies about vaccine trials.
(Reporting by Daina Beth Solomon)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,050 GBX | -0.87% | +0.52% | +13.68% |
03:54pm | Cellectis: alliance with AstraZeneca finalized | CF |
10:23am | Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca | MT |
Mexican President Andres Manuel Lopez Obrador said on Wednesday the country has "other options" for a potential COVID-19 vaccine after drugmaker AstraZeneca Plc suspended a late-stage trial due to an illness in a participant.
The governments of Argentina and Mexico have agreed to produce the AstraZeneca COVID-19 vaccine for most of Latin America. Mexico is in talks with several companies about vaccine trials.
(Reporting by Daina Beth Solomon)
1st Jan change | Capi. | |
---|---|---|
+13.68% | 234B | |
+28.50% | 662B | |
+22.23% | 546B | |
-4.93% | 359B | |
+16.97% | 323B | |
+4.08% | 289B | |
+3.84% | 198B | |
-10.35% | 194B | |
+3.98% | 167B | |
-2.26% | 157B |